254 related articles for article (PubMed ID: 18393803)
41. Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model.
Ohno M; Hiraoka Y; Lichtenthaler SF; Nishi K; Saijo S; Matsuoka T; Tomimoto H; Araki W; Takahashi R; Kita T; Kimura T; Nishi E
Neurobiol Aging; 2014 Jan; 35(1):213-22. PubMed ID: 23954170
[TBL] [Abstract][Full Text] [Related]
42. Intranasal Lactoferrin Enhances α-Secretase-Dependent Amyloid Precursor Protein Processing via the ERK1/2-CREB and HIF-1α Pathways in an Alzheimer's Disease Mouse Model.
Guo C; Yang ZH; Zhang S; Chai R; Xue H; Zhang YH; Li JY; Wang ZY
Neuropsychopharmacology; 2017 Dec; 42(13):2504-2515. PubMed ID: 28079060
[TBL] [Abstract][Full Text] [Related]
43. Carnosic acid suppresses the production of amyloid-β 1-42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells.
Meng P; Yoshida H; Matsumiya T; Imaizumi T; Tanji K; Xing F; Hayakari R; Dempoya J; Tatsuta T; Aizawa-Yashiro T; Mimura J; Kosaka K; Itoh K; Satoh K
Neurosci Res; 2013 Feb; 75(2):94-102. PubMed ID: 23257508
[TBL] [Abstract][Full Text] [Related]
44. Shedding of the amyloid precursor protein-like protein APLP2 by disintegrin-metalloproteinases.
Endres K; Postina R; Schroeder A; Mueller U; Fahrenholz F
FEBS J; 2005 Nov; 272(22):5808-20. PubMed ID: 16279945
[TBL] [Abstract][Full Text] [Related]
45. PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.
Pietri M; Dakowski C; Hannaoui S; Alleaume-Butaux A; Hernandez-Rapp J; Ragagnin A; Mouillet-Richard S; Haik S; Bailly Y; Peyrin JM; Launay JM; Kellermann O; Schneider B
Nat Med; 2013 Sep; 19(9):1124-31. PubMed ID: 23955714
[TBL] [Abstract][Full Text] [Related]
46. Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding.
Parvathy S; Ehrlich M; Pedrini S; Diaz N; Refolo L; Buxbaum JD; Bogush A; Petanceska S; Gandy S
J Neurochem; 2004 Aug; 90(4):1005-10. PubMed ID: 15287907
[TBL] [Abstract][Full Text] [Related]
47. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin.
Tippmann F; Hundt J; Schneider A; Endres K; Fahrenholz F
FASEB J; 2009 Jun; 23(6):1643-54. PubMed ID: 19144697
[TBL] [Abstract][Full Text] [Related]
48. Revisiting APP secretases: an overview on the holistic effects of retinoic acid receptor stimulation in APP processing.
Vitória JJM; Trigo D; da Cruz E Silva OAB
Cell Mol Life Sci; 2022 Jan; 79(2):101. PubMed ID: 35089425
[TBL] [Abstract][Full Text] [Related]
49. ADAMs family members as amyloid precursor protein alpha-secretases.
Allinson TM; Parkin ET; Turner AJ; Hooper NM
J Neurosci Res; 2003 Nov; 74(3):342-52. PubMed ID: 14598310
[TBL] [Abstract][Full Text] [Related]
50. Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease.
Bandyopadhyay S; Goldstein LE; Lahiri DK; Rogers JT
Curr Med Chem; 2007; 14(27):2848-64. PubMed ID: 18045131
[TBL] [Abstract][Full Text] [Related]
51. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism.
Vingtdeux V; Hamdane M; Gompel M; Bégard S; Drobecq H; Ghestem A; Grosjean ME; Kostanjevecki V; Grognet P; Vanmechelen E; Buée L; Delacourte A; Sergeant N
Neurobiol Dis; 2005 Nov; 20(2):625-37. PubMed ID: 15936948
[TBL] [Abstract][Full Text] [Related]
52. Regulation of α-secretase ADAM10 expression and activity.
Endres K; Fahrenholz F
Exp Brain Res; 2012 Apr; 217(3-4):343-52. PubMed ID: 21969210
[TBL] [Abstract][Full Text] [Related]
53. New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing alpha-secretase activity.
Yang HQ; Pan J; Ba MW; Sun ZK; Ma GZ; Lu GQ; Xiao Q; Chen SD
Eur J Neurosci; 2007 Jul; 26(2):381-91. PubMed ID: 17650113
[TBL] [Abstract][Full Text] [Related]
54. The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis.
Hoe HS; Cooper MJ; Burns MP; Lewis PA; van der Brug M; Chakraborty G; Cartagena CM; Pak DT; Cookson MR; Rebeck GW
J Neurosci; 2007 Oct; 27(40):10895-905. PubMed ID: 17913923
[TBL] [Abstract][Full Text] [Related]
55. P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing.
Camden JM; Schrader AM; Camden RE; González FA; Erb L; Seye CI; Weisman GA
J Biol Chem; 2005 May; 280(19):18696-702. PubMed ID: 15778502
[TBL] [Abstract][Full Text] [Related]
56. Cilostazol suppresses β-amyloid production by activating a disintegrin and metalloproteinase 10 via the upregulation of SIRT1-coupled retinoic acid receptor-β.
Lee HR; Shin HK; Park SY; Kim HY; Lee WS; Rhim BY; Hong KW; Kim CD
J Neurosci Res; 2014 Nov; 92(11):1581-90. PubMed ID: 24903973
[TBL] [Abstract][Full Text] [Related]
57. Altered processing of the amyloid precursor protein and decreased expression of ADAM 10 by chronic hypoxia in SH-SY5Y: no role for the stress-activated JNK and p38 signalling pathways.
Webster NJ; Green KN; Settle VJ; Peers C; Vaughan PF
Brain Res Mol Brain Res; 2004 Nov; 130(1-2):161-9. PubMed ID: 15519686
[TBL] [Abstract][Full Text] [Related]
58. Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of alpha-, beta- and gamma-secretase expression.
Quiroz-Baez R; Rojas E; Arias C
Neurochem Int; 2009 Dec; 55(7):662-70. PubMed ID: 19560504
[TBL] [Abstract][Full Text] [Related]
59. Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17.
Deuss M; Reiss K; Hartmann D
Curr Alzheimer Res; 2008 Apr; 5(2):187-201. PubMed ID: 18393804
[TBL] [Abstract][Full Text] [Related]
60. The transmembrane domain of the amyloid precursor protein is required for antiamyloidogenic processing by α-secretase ADAM10.
Hitschler L; Lang T
J Biol Chem; 2022 Jun; 298(6):101911. PubMed ID: 35398353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
